Share chart Digipath Inc
Extended chart
Simple chart
About
Hypha Labs, Inc., cultivates, produces, and sells psychedelic and functional mushroom in the United States. It has developed technology that quickly cultivates the mycelium root structures of psilocybin mushrooms and other functional mushroom's mycelium into a natural product. The company was incorporated in 2010 and is headquartered in Las Vegas, Nevada.
| ISIN |
US2538252022 |
| Industry |
Health Care Providers & Services |
| Sector |
Health Care |
| Валюта |
usd |
| Валюта отчета |
usd |
| Сайт |
https://hyphalabs.com
|
| Цена ао |
0.0236 |
| Change price per day: |
0% (0.0236) |
| Change price per week: |
-15.71% (0.028) |
| Change price per month: |
+38.82% (0.017) |
| Change price per 3 month: |
+22.28% (0.0193) |
| Change price per half year: |
+38.82% (0.017) |
| Change price per year: |
+12.38% (0.021) |
| Change price per 3 year: |
-56.7% (0.0545) |
| Change price per 5 year: |
-80.33% (0.12) |
| Change price per 10 year: |
0% (0.0236) |
| Change price per year to date: |
-41% (0.04) |
|
|
Underestimation
| Title |
Value |
Grade |
| P/S |
0 |
0 |
| P/BV |
0 |
0 |
| P/E |
0 |
0 |
| EV/EBITDA |
0 |
0 |
| Total: |
|
2.5 |
|
Efficiency
| Title |
Value |
Grade |
| ROA, % |
0 |
0 |
| ROE, % |
0 |
0 |
| Total: |
|
0 |
|
|
|
Dividends
| Title |
Value |
Grade |
| Div yield, % |
0 |
0 |
| DSI |
0 |
0 |
| Total: |
|
0.1 |
|
Debt
| Title |
Value |
Grade |
| Debt/EBITDA |
0 |
10 |
| Total: |
|
10 |
|
Growth impulse
| Title |
Value |
Grade |
| Yield Revenue, % |
-4.93 |
0 |
| Yield Ebitda, % |
-49.07 |
0 |
| Yield EPS, % |
-89.25 |
0 |
| Total: |
|
0 |
|
| Head |
Job title |
Payment |
Year of birth |
| Mr. A. Stone Douglass |
Chairman, President, CEO, CFO & Secretary |
|
1948 (77 years) |
| Mr. Dennis Hartmann |
Chief Legal Officer & Independent Director |
|
1956 (69 years) |
| Mr. John Frailey |
Chief Technical Director |
|
|
| Mr. Craig M. Ellins |
Chief Science Officer |
|
1952 (73 years) |
